Fundraising Fox

Cognito

Founded 2021 · 14 employees on LinkedIn · 2 known investors

Cognito provides online mental health care including diagnosis, medication management, and CBT-based care coaching, with a focus on conditions such as ADHD. The service is delivered remotely to individuals in Canada seeking accessible mental health treatment.

Also known as Cognito Health

Investors · 2

Company profile

researched Aug 2026

Cognito (also referred to as Cognito Health) is a Canadian telehealth provider of one-on-one virtual mental health treatment. Its programs cover mild to moderate anxiety, depression, insomnia, ADHD, burnout, stress, low mood, and self-esteem and confidence concerns. Core services include comprehensive ADHD diagnostic assessments conducted by CADDRA-trained nurse practitioners using evidence-based diagnostic tools, nurse-practitioner-led treatment that can involve medication options, lab orders and preliminary assessment, one-on-one virtual Cognitive Behavioural Therapy delivered by a CBT Care Provider on a biweekly schedule, and psychiatrist-led group therapy sessions.

The care pathway begins with an intake questionnaire and initial assessment with a nurse practitioner or registered nurse, followed by a virtual assessment, recurring CBT sessions, and ongoing clinical surveys used by the client and care team to track and adjust treatment. The company also offers self-paced mental health courses and medication fulfilment and delivery where required. Cognito describes a 12-week program framing and a team-based, value-based care approach.

Business model

Direct-to-consumer subscription and fee-based virtual care. The Core Mental Health program is sold as a monthly subscription starting at $89 per month, bundling one-on-one nurse practitioner appointments, twice-monthly CBT appointments, prescription medication and its fulfilment and delivery if required, optional group therapy, and self-paced courses. A separate ADHD Diagnosis program is sold as a one-time $499 fee covering intake, anxiety and depression screening, labs and ECG if indicated, a full diagnostic assessment, and a proof-of-diagnosis letter, with options to continue into skills-based therapy or medication. The site also references an employer-facing offering.

Recurring monthly program fees and one-time diagnostic assessment fees paid by clients, with an employer channel referenced on the site.

Traction

The company states it is used by thousands of Canadians and publishes client testimonials, including from a client reporting more than a year of continuous use.

Full profile — market position, technology, go-to-market, geography

Market position

Positions itself as an accessible, affordable alternative to conventional wait-list-bound mental health care in Canada, stating it is trusted by thousands of Canadians.

Combines diagnosis, medication management, one-on-one CBT and psychiatrist-led group therapy within a single team-based program rather than offering these separately; uses CADDRA-trained nurse practitioners for ADHD assessment and tracks outcomes through repeated clinical surveys.

Technology

Virtual care delivery via one-on-one video appointments, an online intake and free self-assessment flow, evidence-based diagnostic instruments used in ADHD assessment, recurring clinical surveys for outcome tracking, and self-paced digital mental health courses.

Go-to-market

Online direct-to-consumer sign-up through the company website, supported by a free self-assessment tool, published client reviews, transparent program pricing, and location-specific pages for Ontario, British Columbia, Toronto and Victoria. An employers page indicates a business-to-business channel alongside consumer acquisition.

Adults in Canada seeking accessible treatment for mild to moderate anxiety, depression, insomnia, ADHD, burnout, stress, low mood, and self-esteem concerns, plus employers sourcing mental health benefits.

Geography

Operates in Canada with a head office in Victoria, British Columbia, and listed service locations in Ontario and British Columbia, including Toronto and Victoria.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
ADHD Diagnosis program priceJan 2024$499
Core Mental Health program priceJan 2024$89
Program durationJan 202412 weeks

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Cognito do?
Canadian virtual mental health provider offering ADHD assessments, nurse-practitioner-led treatment and CBT programs.
Who are Cognito's investors?
Cognito's investors include Garage Capital, Graphite Ventures.